2-year Mortality After COVID-19 in Nursing Home Residents

This was a retrospective study conducted in three Nursing Homes (NHs). Residents who had survived the 1st CoPW (March to May 2020) were included. The diagnosis of COVID-19 was based on the results of a positive reverse transcriptase-polymerase chain reaction test. The collected data also included age, sex, length of residence in the NH, disability status, legal guardianship status, nutritional status, need for texture-modified food, hospitalization or Emergency Department visits during lockdown and SARS-COV2 vaccination status during the follow-up. Non-adjusted and adjusted Cox models were used to analyse factors associated with 2-year post-1stCoPW mortality.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

70 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Geriatrics

Paris, 75018, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Living in one of the Nursing Homes during the fiorst COVID-19 pandemic wave
Having survived the first pandemic wave

Exclusion criteria

Residents who died during the first pandemic wave
Refusal for articipation to the study

Treatment and study plan

Primary outcomes

All cause mortality

Time frame: months

Sponsors and collaborators

Lead sponsor

Bichat Hospital

Other

Registry information

Official study title

COVID-19 Infection and 2-year Mortality in Nursing Home Residents Who Survived the First Wave of the Pandemic

Important dates

Study start: 2020
Primary completion: 2022
Study completion: 2022
First posted: Jun 21, 2024
Registry last updated: Jun 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed